Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease

Dilan A Patel, MD, Josu de la Fuente, Michael Matheney, MD, Leena Karnik, FRCPath, MRCP, Heidi Chen, PhD, Katie S. Gatwood, PharmD, Kathryn A. Culos, PharmD, Karina L Wilkerson, NP, MSN, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Stacey Ann Goodman, MD, Bhagirathbhai Dholaria, MBBS, Bipin N. Savani, MD, Wichai Chinratanalab, MD, Reena Jayani, MD, Jim Connelly, MD, Carrie Kitko, MD, Brian G. Engelhardt, MD, Adetola A. Kassim, MDMS

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-143039

Published: 2020

Journal Articles

Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations

Uttam K. Rao, MD MBA, Heidi Chen, PhD, Katie S. Gatwood, PharmD, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Stacey A. Goodman, MD, Bhagirathbhai Dholaria, MBBS, Adetola A. Kassim, MDMS, Bipin N. Savani, MD, Wichai Chinratanalab, MD, Kathryn A. Culos, PharmD, Michael R. Savona, MD, Brian G. Engelhardt, MD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-137712

Published: 2020

Journal Articles

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Ameet Patel, MD, Karina L Wilkerson, NP, MSN, Kathryn A. Culos, PharmD, Jennifer Green, MD, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Bhagirathbhai Dholaria, MBBS, Bipin N. Savani, MD, Stacey Ann Goodman, MD, Wichai Chinratanalab, MD, Reena Jayani, MD, Katie S. Gatwood, PharmD, Brian G. Engelhardt, MD, Adetola A. Kassim, MDMS

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138499

Published: 2020

Journal Articles

Outcomes of a Novel Rituximab-Based Non-Ablative Conditioning Regimen for Hematopoietic Cell Transplantation in Severe Aplastic Anemia

Katie S Gatwood, PharmD, Kathryn A Culos, PharmD, Laura A Binari, MD, Brian G Engelhardt, MD, Adetola A. Kassim, MD MS, Michael Byrne, MD, Stacey A Goodman, MD MS, Wichai Chinratanalab, MD, Salyka M. Sengsayadeth, MD, John P. Greer, MD, Madan Jagasia, MD MBBS, MS, Bipin N. Savani, MD

Blood (2017) 130 (Supplement 1): 3210.

https://doi.org/10.1182/blood.V130.Suppl_1.3210.3210

Published: 2017

Journal Articles

Similar Outcomes of Early Failure Steroid Dependent Acute GvHD and Upfront Steroid Refractory Acute GvHD: Implications on Clinical Trials

Karina A Mendoza, BS, Heidi Chen, PhD, Brian G Engelhardt, MD, Bipin N. Savani, MD, Stacey A Goodman, MD MS, Jeremy Warner, MD MS, Adetola A. Kassim, MD MS, Michael Byrne, MD, Wichai Chinratanalab, MD, John P. Greer, MD, Carole Hunt, Madan Jagasia, MD MBBS, MS

Blood (2017) 130 (Supplement 1): 1975.

https://doi.org/10.1182/blood.V130.Suppl_1.1975.1975

Published: 2017

Journal Articles

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Christopher Strouse, MD, Ying Zhang, Mei-Jie Zhang, PhD, Alyssa DiGilio, MS, Marcelo C. Pasquini, MD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD, Muthalagu Ramanathan, MD, Wichai Chinratanalab, MD, Alison W Loren, MD MS, Linda J. Burns, MD, Andrew Artz, MD, Kathleen F. Villa, MS, Wael Saber, MD MS

Blood (2016) 128 (22): 983.

https://doi.org/10.1182/blood.V128.22.983.983

Published: 2016

Journal Articles

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Zhuoyan Li, MD, Samuel M Rubinstein, MD, Carey Clifton, ACNP, Leigh Ann Vaughan, ACNP, Melissa Logue, ACNP, Michael T. Byrne, DO, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Wichai Chinratanalab, MD, Salyka Sengsayadeth, MD, Stephen J. Brandt, MD, Stacey A. Goodman, MD MS, John P. Greer, MD, Madan Jagasia, MD, Bipin N. Savani, MD

Blood (2016) 128 (22): 3438.

https://doi.org/10.1182/blood.V128.22.3438.3438

Published: 2016

Journal Articles

Tacrolimus Metabolism and Risk of Acute Graft Versus Host Disease

Mary Christa Krupski, DO, MPH, Andrew Bodiford, PharmD, Kathryn Culos, PharmD, BCOP, Adetola A. Kassim, MD MS, Brian G. Engelhardt, MD, John P. Greer, MD, Bipin N. Savani, MD, Wichai Chinratanalab, MD, Madan Jagasia, MBBS, MS

Blood (2015) 126 (23): 1954.

https://doi.org/10.1182/blood.V126.23.1954.1954

Published: 2015

Journal Articles

Reduced Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes When Compared to Fludarabine and Busulfan Following Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies

Vanessa E Kennedy, BS, Bipin N. Savani, MD, John P. Greer, MD, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Stacey A. Goodman, MD MS, Salyka M. Sengsayadeth, MD, Wichai Chinratanalab, MD, Madan H. Jagasia

Blood (2015) 126 (23): 4409.

https://doi.org/10.1182/blood.V126.23.4409.4409

Published: 2015

Journal Articles

Optimizing Anti-Thymocyte Globulin Dosing Based on Recipient Absolute Lymphocyte Count after Unrelated Allogeneic Hematopoietic Cell Transplant

Vanessa E Kennedy, BS, Heidi Chen, Bipin N. Savani, MD, John P. Greer, MD, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Stacey A. Goodman, MD MS, Salyka M. Sengsayadeth, MD, Wichai Chinratanalab, MD, Madan H. Jagasia

Blood (2015) 126 (23): 4410.

https://doi.org/10.1182/blood.V126.23.4410.4410

Published: 2015

Journal Articles

Incidence and Risk Factors Associated with Clostridium Difficile Infection in Cord Blood Transplant

Mirat Shah, MD, Bridget Ory Dickerson, MD, Bipin N. Savani, MD, Lora Thomas, MD, Wichai Chinratanalab, MD, Brian Engelhardt, MD, Stacey Goodman, MD, John P Greer, MD, Adetola A. Kassim, MD, Salyka Sengsayadeth, MD, Madan Jagasia, MBBS, MS

Blood (2014) 124 (21): 3868.

https://doi.org/10.1182/blood.V124.21.3868.3868

Published: 2014

Journal Articles

Impact of Different Mobilization Methods on Graft Composition and Outcome after Autologous Stem Cell Transplantation: Implications for Upfront Use of Plerixafor

LaQuisa Hill, MD, Oluchi C. Ukaegbu, MD, Bipin N. Savani, MD, Salyka Sengsayadeth, MD, Stacey Goodman, MD, Stephen J. Brandt, MD, Wichai Chinratanalab, MD

Blood (2014) 124 (21): 1125.

https://doi.org/10.1182/blood.V124.21.1125.1125

Published: 2014

Journal Articles

Comparison of Autologous Vs. Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma

Nishitha M. Reddy, MD, Olalekan O Oluwole, MBBS, MPH, John P Greer, MD, David S Morgan, MD, Stacey Goodman, MD, Brian Engelhardt, MD, Wichai Chinratanalab, MD, Adetola A Kassim, MD, Madan Jagasia, MBBS, MS, Bipin N. Savani, MD

Blood (2012) 120 (21): 2036.

https://doi.org/10.1182/blood.V120.21.2036.2036

Published: 2012

Journal Articles

Six Month Freedom From Steroid Failure Complements Day 28 Response to Steroids As a Predictor of Survival After Acute Graft-Versus-Host Disease Treatment

Salyka M. Sengsayadeth, MD, Madan Jagasia, MBBS, MS, John P. Greer, MD, Heidi Chen, PhD, Stacey Goodman, MD, Wichai Chinratanalab, MD, Adetola A Kassim, MD, Bipin N. Savani, MD, Brian G Engelhardt, MD, MSCI

Blood (2012) 120 (21): 4187.

https://doi.org/10.1182/blood.V120.21.4187.4187

Published: 2012

Journal Articles

Pharmacoeconomics of Stem Cell Mobilization Using Cyclophosphamide and G-Csf.

Madan Jagasia, MD, MS, Heidi Chen, PhD, Sheri Dixon, Jodene Hume-Rowland, Bipin N. Savani, MD, Anne T. Neff, MD, Kimberely Moyers, Wichai Chinratanalab, MD, Friedrich Schuening, MD

Blood (2009) 114 (22): 4526.

https://doi.org/10.1182/blood.V114.22.4526.4526

Published: 2009

Journal Articles

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

Carey Clifton, Leigh Ann Vaughan, Catherine Lucid, Sharon Sims, Brian Engelhardt, MD, Wichai Chinratanalab, MD, Adetola A. Kassim, MD, MS, Stacey Goodman, MD, John P. Greer, MD, Friedrich Schuening, MD, Madan Jagasia, MD, MS, Bipin N. Savani, MD

Blood (2009) 114 (22): 3330.

https://doi.org/10.1182/blood.V114.22.3330.3330

Published: 2009

Journal Articles

Nucleated Cell (NC) Dose of Autologous (Auto) Marrow Graft Is Not Predictive of Engraftment after Auto-Bone Marrow Transplant (auto-BMT) Following Failed Peripheral Blood Stem Cell (PBSC) Mobilization.

Stephen A. Strickland, MD, Heidi Chen, PhD, Carole Hunt, RN, Wichai Chinratanalab, MD, Brian Engelhardt, MD, Stacey A. Goodman, MD, John P. Greer, MD, Adetola A. Kassim, MD, David Morgan, MD, Katherine L. Ruffner, MD, Friedrich Schuening, MD, Madan Jagasia, MBBS, MS

Blood (2006) 108 (11): 5454.

https://doi.org/10.1182/blood.V108.11.5454.5454

Published: 2006

Journal Articles

Predictive Value for Engraftment and Survival of Total Nucleated Cell Dose (TNC) as Compared to CD34 + Cell Dose after Autologous and Allogeneic Bone Marrow Transplant (BMT) for Hematologic Malignancies.

Adetola A. Kassim, MD, Shin Mineishi, MD, Madan Jagasia, MD, Madhuri Vurisikala, MD, Stacey Goodman, MD, John P. Greer, MD, Wichai Chinratanalab, MD, Katherine Ruffner, MD, David S. Morgan, MD, Richard S. Stein, MD, Stephen Brandt, MD, Friedrich G. Schuening, MD

Blood (2004) 104 (11): 5055.

https://doi.org/10.1182/blood.V104.11.5055.5055

Published: 2004

Journal Articles

Post-Transplant Positron Emission Tomography Using Fluorine 18-Fluoro-Deoxyglucose ([ 18 F]FDG-PET) Correlates with Outcome in Patients with Aggressive Non-Hodgkin’s Lymphoma Undergoing High Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation (HDC/ASCT).

Adetola A. Kassim, MD, Shin Mineishi, MD, John P. Greer, MD, Natalie McVay, Tatsuki Koyama, PhD, Wichai Chinratanalab, MD, Stephen J. Brandt, MD, Madan Jagasia, MD, Katherine Ruffner, MD, Friedrich G. Schuening, MD, Richard S. Stein, MD, Madhuri Vusirikala, MD, Stacey Goodman, MD, David S. Morgan, MD

Blood (2004) 104 (11): 906.

https://doi.org/10.1182/blood.V104.11.906.906

Published: 2004

NARROW

Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease

Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of a Novel Rituximab-Based Non-Ablative Conditioning Regimen for Hematopoietic Cell Transplantation in Severe Aplastic Anemia

Similar Outcomes of Early Failure Steroid Dependent Acute GvHD and Upfront Steroid Refractory Acute GvHD: Implications on Clinical Trials

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Tacrolimus Metabolism and Risk of Acute Graft Versus Host Disease

Reduced Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes When Compared to Fludarabine and Busulfan Following Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies

Optimizing Anti-Thymocyte Globulin Dosing Based on Recipient Absolute Lymphocyte Count after Unrelated Allogeneic Hematopoietic Cell Transplant

Incidence and Risk Factors Associated with Clostridium Difficile Infection in Cord Blood Transplant

Impact of Different Mobilization Methods on Graft Composition and Outcome after Autologous Stem Cell Transplantation: Implications for Upfront Use of Plerixafor

Comparison of Autologous Vs. Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma

Six Month Freedom From Steroid Failure Complements Day 28 Response to Steroids As a Predictor of Survival After Acute Graft-Versus-Host Disease Treatment

Pharmacoeconomics of Stem Cell Mobilization Using Cyclophosphamide and G-Csf.

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

Nucleated Cell (NC) Dose of Autologous (Auto) Marrow Graft Is Not Predictive of Engraftment after Auto-Bone Marrow Transplant (auto-BMT) Following Failed Peripheral Blood Stem Cell (PBSC) Mobilization.

Predictive Value for Engraftment and Survival of Total Nucleated Cell Dose (TNC) as Compared to CD34 + Cell Dose after Autologous and Allogeneic Bone Marrow Transplant (BMT) for Hematologic Malignancies.

Post-Transplant Positron Emission Tomography Using Fluorine 18-Fluoro-Deoxyglucose ([ 18 F]FDG-PET) Correlates with Outcome in Patients with Aggressive Non-Hodgkin’s Lymphoma Undergoing High Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation (HDC/ASCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only